Stocks
April 29, 2026
Anomaly01STOCKS
Erasca crashes 48% on 7x volume after patient death in pancreatic cancer trial
Erasca (ERAS) fell 48% day-over-day — touching an intraday low of $8.70, a 54% drop from its prior close of $19.15 — before closing at $9.90, after a patient in its pancreatic cancer trial died following severe lung inflammation. The session erased roughly $2.9 billion in market value from a stock that had surged more than 400% year-to-date.
Divergence02STOCKS
BSX hits a 52-week low with 26 EPS cuts while peer ISRG collects 23 upgrades — same 7-day window
Boston Scientific (BSX) closed at its 52-week low of $58.45 — down 46% from its 52-week high of $108.14 — with analysts cutting its FY EPS consensus 26 times in 7 days and zero upgrades, pulling the estimate from $3.46 to $3.38. Over the identical period, sector peer Intuitive Surgical (ISRG) received 23 upgrades and zero cuts, with its FY consensus rising 4.1% to $10.41.
Trend Shift03STOCKS
Vertiv gets 22 FY EPS upgrades with zero cuts as consensus jumps 5.4% in 7 days
Vertiv (VRT) collected 22 upward FY EPS revisions in 7 days with zero cuts — tied for the highest upgrade count in the dataset — pushing the FY 2026 consensus from $6.16 to $6.49 (+5.4%) in one week. The stock closed at $305.03 on April 28, up ~9% from its April 8 low of $281.03, and sits 7.6% below its 52-week high of $330.30 reached on April 24.
Divergence04STOCKS
Lam Research gains 23 FY EPS upgrades but stock declines as export ban to Hua Hong emerges; peers gain
Lam Research (LRCX) accumulated 23 upward FY EPS revisions in 7 days with zero cuts, lifting the FY consensus 6.4% to $5.68. However, the stock closed down 0.5% on April 28 following a day in which it had already declined 5-6% amid news of a US Commerce Department order halting tool shipments to Hua Hong, China's second-largest chipmaker. Peers AMD and QCOM gained 3.6% and 3.2% on the same day.